JPWO2022230974A1 - - Google Patents
Info
- Publication number
- JPWO2022230974A1 JPWO2022230974A1 JP2023517621A JP2023517621A JPWO2022230974A1 JP WO2022230974 A1 JPWO2022230974 A1 JP WO2022230974A1 JP 2023517621 A JP2023517621 A JP 2023517621A JP 2023517621 A JP2023517621 A JP 2023517621A JP WO2022230974 A1 JPWO2022230974 A1 JP WO2022230974A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/712—Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7125—Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021076521 | 2021-04-28 | ||
| PCT/JP2022/019273 WO2022230974A1 (ja) | 2021-04-28 | 2022-04-28 | 抗ウイルス核酸 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022230974A1 true JPWO2022230974A1 (https=) | 2022-11-03 |
| JPWO2022230974A5 JPWO2022230974A5 (https=) | 2025-05-09 |
Family
ID=83848558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023517621A Withdrawn JPWO2022230974A1 (https=) | 2021-04-28 | 2022-04-28 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240229035A1 (https=) |
| EP (1) | EP4332223A4 (https=) |
| JP (1) | JPWO2022230974A1 (https=) |
| CN (1) | CN117203339A (https=) |
| TW (1) | TW202309282A (https=) |
| WO (1) | WO2022230974A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023171804A1 (ja) * | 2022-03-10 | 2023-09-14 | 日本新薬株式会社 | 抗ウイルスアンチセンスオリゴマー |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7339051B2 (en) * | 2003-04-28 | 2008-03-04 | Isis Pharmaceuticals, Inc. | Compositions and methods for the treatment of severe acute respiratory syndrome (SARS) |
| US20050171044A1 (en) * | 2003-12-24 | 2005-08-04 | Stein David A. | Oligonucleotide compound and method for treating nidovirus infections |
| PL2735568T3 (pl) * | 2006-05-10 | 2018-02-28 | Sarepta Therapeutics, Inc. | Analogi oligonukleotydowe mające kationowe połączenia pomiędzy podjednostkami |
| CN111321142A (zh) * | 2020-02-05 | 2020-06-23 | 翁炳焕 | 一种新型冠状病毒肺炎dsRNA疫苗的制备方法 |
| CN111330003A (zh) * | 2020-03-23 | 2020-06-26 | 翁炳焕 | 一种新冠肺炎反义rna多价疫苗的制备方法 |
| WO2021195025A1 (en) * | 2020-03-25 | 2021-09-30 | City Of Hope | Antisense rna for treatment of sars-associated coronavirus |
| CN111778253B (zh) | 2020-04-03 | 2022-02-18 | 苏州吉玛基因股份有限公司 | 一种小干扰核酸及组合物和应用 |
| CN111748557B (zh) | 2020-04-03 | 2022-03-11 | 苏州吉玛基因股份有限公司 | 抑制新型冠状病毒的小干扰核酸及组合物和应用 |
| WO2021224918A1 (en) * | 2020-05-07 | 2021-11-11 | Eleven Therapeutics Ltd. | Utilizing rna interference against sars-cov-2 |
| JPWO2021241040A1 (https=) * | 2020-05-27 | 2021-12-02 | ||
| CN112111489A (zh) * | 2020-06-23 | 2020-12-22 | 深圳罗兹曼国际转化医学研究院 | 抑制SARS-COV-2病毒复制的shRNA及其应用 |
| KR102272800B1 (ko) * | 2020-06-30 | 2021-07-05 | 국방과학연구소 | 코로나바이러스 특이적 이중가닥 올리고뉴클레오티드 및 이를 포함하는 코로나바이러스 감염증-19 예방 및 치료용 조성물 |
-
2022
- 2022-04-28 EP EP22795887.3A patent/EP4332223A4/en active Pending
- 2022-04-28 US US18/557,883 patent/US20240229035A1/en active Pending
- 2022-04-28 WO PCT/JP2022/019273 patent/WO2022230974A1/ja not_active Ceased
- 2022-04-28 TW TW111116238A patent/TW202309282A/zh unknown
- 2022-04-28 CN CN202280031074.4A patent/CN117203339A/zh not_active Withdrawn
- 2022-04-28 JP JP2023517621A patent/JPWO2022230974A1/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP4332223A1 (en) | 2024-03-06 |
| US20240229035A1 (en) | 2024-07-11 |
| WO2022230974A1 (ja) | 2022-11-03 |
| TW202309282A (zh) | 2023-03-01 |
| EP4332223A4 (en) | 2025-12-31 |
| CN117203339A (zh) | 2023-12-08 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A529 | Written submission of copy of amendment under article 34 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A5211 Effective date: 20231019 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231031 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250425 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250425 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20251212 |